R.S.B. Pharma Private Limited
Founded in 2002 and headquartered in Delhi, India.
2002 | Delhi, Delhi (India) | Active
R.S.B. Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.30 M
- Revenue Growth 0.51%
- Profit Growth 10.69%
- Ebitda 56.10%
- Net Worth 7.26%
- Total Assets 9.64%
About R.S.B. Pharma
R.S.B. Pharma Private Limited (RPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 July 2002 and has a history of 22 years and seven months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.30 M.
Rakesh Tuteja, Baldev Tuteja, and Sachin Arora serve as directors at the Company.
Company Details
- Location
Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL2002PTC116108
- Company No.
116108
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does R.S.B. Pharma Private Limited offer?
R.S.B. Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Common Disease Medicines, Pharmaceutical Capsules, Oral Care Products, IV Fluids, Multivitamin Tablets & Capsules, Eye Drops.
Who are the key members and board of directors at R.S.B. Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Tuteja  | Director | 05-Jul-2002 | Current |
| Baldev Tuteja | Director | 05-Jul-2002 | Current |
| Sachin Arora | Director | 05-Jul-2002 | Current |
Financial Performance of R.S.B. Pharma.
R.S.B. Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.51% increase. The company also saw a substantial improvement in profitability, with a 10.69% increase in profit. The company's net worth moved up by a moderate rise of 7.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.S.B. Pharma?
In 2023, R.S.B. Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Human Rise Pharma Private LimitedRakesh Tuteja, Baldev Tuteja and 1 more are mutual person
Charges (Loans)
Open Charges
₹2.30 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Dcb Bank Limited : 0.21 Cr
- Vijaya Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2014 | Dcb Bank Limited | ₹2.10 M | Open |
| 11 Dec 2002 | Vijaya Bank | ₹0.20 M | Open |
How Many Employees Work at R.S.B. Pharma?
Unlock and access historical data on people associated with R.S.B. Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.S.B. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.S.B. Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.